The authors found significantly decreased vitreous levels of Aβ (1–42) (consistent with Aβ deposition in the retina) and significantly increased vitreous levels of tau in patients with glaucoma in comparison with the levels in a control group [16, 21]. The gene discussed is MAPT; the disease is glaucoma.